A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers

Thrombosis Research

Volumn 125, Issue 2, 2010, Pages

  Ozeki, Michio ^a   Kunishima, Shinji ^b   Kasahara, Kimiko ^a   Funato, Michinori ^a   Teramoto, Takahide ^a   Kaneko, Hideo ^a   Fukao, Toshiyuki ^a   Kondo, Naomi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

giant platelets; polymorphism; thrombocytopenia; type 2B von Willebrand disease; von Willebrand factor

Indexed keywords

HIGH MOLECULAR WEIGHT MULTIMER; IMMUNOGLOBULIN; POLYMER; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD EXAMINATION; CASE REPORT; CHILD; DISEASE SEVERITY; DRUG MEGADOSE; FAMILY; FEMALE; GENE MUTATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; MALE; MOLECULAR WEIGHT; PLASMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SIBLING; STRESS; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

BLOOD COAGULATION TESTS; BLOOD PLATELETS; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; HUMANS; MALE; MOLECULAR WEIGHT; MUTATION; PLATELET COUNT; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE, TYPE 2; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 76449083084     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.08.012     Document Type: Article

References (21)

1. Schneppenheim R., Thomas K.B., and Sutor A.H. Von Willebrand disease in childhood. Semin Thromb Hemost 21 3 (1995) 261-275
2. Werner E.J. Von Willebrand disease in children and adolescents. Pediatr Clin North Am 43 3 (1996) 683-707
3. Nurden P., Debili N., Vainchenker W., Bobe R., Bredoux R., Corvazier E., et al. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood 108 (2006) 2587-2595
4. Noris P., Pecci A., Bari F.D., Stazio M.T., Pumpo M.D., Ceresa I.F., et al. Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. Haematologica 89 (2004) 1219-1225
5. Holmberg L., Nilsson I.M., Borge L., Gunnarsson M., and Sjorin E. Platelet aggregation induced by 1-desamino-8-arginine vasopressin (DDAVP) in Type 2B von Willebrand's disease. N Engl J Med 309 (1983) 816-821
6. Rick M.E., Williams S.B., Sacher R.A., and McKeown L.P. Thrombocytopenia associated with pregnancy in a patient with type 2B von Willebrand's disease. Blood 69 (1987) 786-789
7. Hultin M.B., and Sussman I.I. Postoperative thrombocytopenia in type IIB von Willebrand disease. Am J Hematol 75 (1990) 86-91
8. Saba H.I., Saba S.R., Dent J., Ruggeri Z.M., and Zimmerman T.S. Type 2B Tampa: A variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates and spontaneous platelet aggregation. Blood 66 (1985) 282-286
9. Mancuso D.J., Tuley E.A., Westfield L.A., Lester-Mancuso T.L., Le Beau M.M., Sorace J.M., et al. Human von Willebrand factor gene and pseudogene: Structual analysis and differentiation by polymerase chain reaction. Biochemistory 30 (1991) 253-269
10. Kunishima S., Matsushita T., Kojima T., Sako M., Kimura F., Jo E.K., et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A (NMMHCA) in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83 (2003) 115-122
11. Kunishima S., and Saito H. Congenital macrothrombocytopenias. Blood Rev 20 (2006) 111-121
12. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryocytes. Nucleic Acid Res 3 (1976) 2303-2308
13. Kanaji T., Okamura T., Kuroiwa M., Murakawa M., Kamura T., and Niho Y. A sequence analysis of von Willebrand factor mRNA, gene, and pseudogene in two patients with von Willebrand disease type 2B, and an investigation of gene conversion in its gene. Int J Hematol 64 (1996) 53-59
14. Eikenboom J.C.J., Reitsma P.H., and Briet E. Seeming homozygosity in type-2B von Willebrand's disease due to a polymorphism within the sequence of a commonly used primer. Ann Hematol 68 (1994) 139-141
15. Federici A.B., Mannucci P.M., Castaman G., Baronciani L., Bucciarelli P., Canciani M.T., et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood 113 (2009) 526-534
16. De Romeuf C., Hilbert L., and Mazurier C. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations. Thromb Haemost 79 (1998) 211-212
17. Cooney K.A., Nichols W.C., Bruck M.E., Bahou W.F., Shapiro A.D., Bowie E.J., et al. The molecular defect in type 2B von Willebrand disease. Identification of four potential missense mutations within the putative GPIb binding domain. J Clin Invest 87 (1991) 1227-1233
18. Cooney K.A., Lyons S.E., and Ginsburg D. Functional analysis of a 2B von Willebrand disease missense mutation: Increased binding of large von Willebrand factor multimers to platelets. Proc Natl Acad Sci 89 (1992) 2869-2872
19. Cooney K.A., and Ginsburg D. Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets. Blood 87 (1996) 2322-2328
20. Othman M., and Favaloro E.J. Genetics of type 2B von Willebrand disease: "true 2B," "tricky 2B," or "not 2B." What are the modifiers of the phenotype?. Semin Thromb Hemost 34 (2008) 520-531
21. Wang Z.J., Onwuzurike N., Callaghan M.U., Rajpurkar M., Chitlur M., and Lusher J.M. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia. Pediatr Blood Cancer 51 (2008) 416-418